Identity
HGNC
LOCATION
7q36.1
LOCUSID
ALIAS
ERG-1,ERG1,H-ERG,HERG,HERG1,Kv11.1,LQT2,SQT1
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 3757
MIM: 152427
HGNC: 6251
Ensembl: ENSG00000055118
Variants:
dbSNP: 3757
ClinVar: 3757
TCGA: ENSG00000055118
COSMIC: KCNH2
RNA/Proteins
Expression (GTEx)
Pathways
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10202 | telithromycin | Chemical | VipGene | associated | 16614168, 16278312 | ||
| PA10407 | calcium channel blockers | Chemical | ClinicalAnnotation | associated | PD | ||
| PA146096020 | nitrendipine | Chemical | ClinicalAnnotation | associated | PD | ||
| PA159018367 | Brugada syndrome | Disease | DataAnnotation | associated | |||
| PA164784002 | sertindole | Chemical | VipGene | associated | 15718164, 16278312, 14999113 | ||
| PA165817938 | prenylamine | Chemical | VipGene | associated | 16278312 | ||
| PA165817939 | pyrilamine | Chemical | VipGene | associated | 16278312 | ||
| PA165817950 | terodiline | Chemical | VipGene | associated | 15718164, 16253929, 14999113 | ||
| PA165818136 | Shortened QT interval | Disease | VipGene | associated | 12829173, 10862094 | ||
| PA165818137 | lidoflazine | Chemical | VipGene | associated | 15718164, 16278312, 14999113 | ||
| PA166157289 | rs1137617 | Variant | VipGene | associated | |||
| PA166157308 | rs1805123 | Variant | VipGene | associated | 11997281, 12829173, 14499861, 14975928, 15746444, 17709632, 18222980, 10862094 | ||
| PA166157459 | rs12720441 | Variant | VipGene | associated | 11997281 | ||
| PA166157488 | rs36210421 | Variant | VipGene | associated | 14975928, 15522280, 17275752, 11468227 | ||
| PA166183774 | short qt syndrome 1 | Disease | ClinicalAnnotation | associated | PD | 16842817 | |
| PA223 | KCNQ1 | Gene | DataAnnotation | associated | |||
| PA25408 | BRAF | Gene | MultilinkAnnotation | associated | 26431495 | ||
| PA304 | SCN5A | Gene | DataAnnotation | associated | |||
| PA444807 | Long QT Syndrome | Disease | VipGene | associated | 14999113, 15522280, 15718164, 15746444, 17143043, 14499861 | ||
| PA445787 | Syncope | Disease | VariantAnnotation | associated | PD | 19057127 | |
| PA446294 | Torsades de Pointes | Disease | ClinicalAnnotation, VariantAnnotation, VipGene | associated | PD | 14999113, 15522280, 15718164, 17143043, 11997281, 19057127 | |
| PA447184 | Romano-Ward Syndrome | Disease | DataAnnotation | associated | |||
| PA447288 | Essential hypertension | Disease | ClinicalAnnotation | associated | PD | ||
| PA447300 | Acquired Long QT Syndrome (aLQTS) | Disease | VariantAnnotation, VipGene | associated | PD | 15522280, 15718164, 17143043, 14999113, 19057127 | |
| PA448383 | amiodarone | Chemical | ClinicalAnnotation, VipGene | associated | PD | 14999113, 11997281 | |
| PA448498 | astemizole | Chemical | VipGene | associated | 14999113, 15718164, 16253929, 18701618, 10376921 | ||
| PA449011 | cisapride | Chemical | VariantAnnotation, VipGene | ambiguous | 14999113, 15718164, 16253929, 18701618, 9374794, 14975928 | ||
| PA449373 | disopyramide | Chemical | ClinicalAnnotation | associated | PD | 16842817 | |
| PA449389 | dofetilide | Chemical | VariantAnnotation, VipGene | associated | PK | 15522280, 18701618, 14999113, 15522280 | |
| PA449409 | doxepin | Chemical | VipGene | associated | |||
| PA449422 | droperidol | Chemical | VipGene | associated | 14999113 | ||
| PA449493 | erythromycin | Chemical | VipGene | associated | 16614168 | ||
| PA449673 | fluoxetine | Chemical | VipGene | associated | 11805215 | ||
| PA449812 | grepafloxacin | Chemical | VipGene | associated | 15718164, 16253929, 14999113 | ||
| PA449841 | haloperidol | Chemical | VipGene | associated | 16278312 | ||
| PA449943 | hydroxyzine | Chemical | VariantAnnotation, VipGene | associated | PD | 19057127 | |
| PA450215 | levomethadyl acetate | Chemical | VipGene | associated | 15718164, 16253929, 14999113 | ||
| PA450401 | methadone | Chemical | VipGene | associated | 17329992, 14999113 | ||
| PA450492 | mibefradil | Chemical | VipGene | associated | 16253929 | ||
| PA450555 | moxifloxacin | Chemical | VipGene | associated | 16614168 | ||
| PA451107 | probucol | Chemical | VipGene | associated | 15043509 | ||
| PA451131 | propafenone | Chemical | VipGene | associated | 16278312 | ||
| PA451209 | quinidine | Chemical | ClinicalAnnotation | associated | PD | 16842817 | |
| PA451619 | terfenadine | Chemical | VipGene | associated | 15718164, 16253929, 18701618, 14999113 | ||
| PA451666 | thioridazine | Chemical | VipGene | associated | 16278312 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37769355 | 2024 | Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes. | 1 |
| 37923359 | 2024 | Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells. | 0 |
| 38086455 | 2024 | Functional and clinical characterization of a novel homozygous KCNH2 missense variant in the pore region of Kv11.1 leading to a viable but severe long-QT syndrome. | 0 |
| 38181028 | 2024 | Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome. | 0 |
| 38181928 | 2024 | Dissecting the associations of KCNH2 genetic polymorphisms with various types of cardiac arrhythmias. | 0 |
| 38219013 | 2024 | Clinical interpretation of KCNH2 variants using a robust PS3/BS3 functional patch-clamp assay. | 3 |
| 38317233 | 2024 | An LQT2-related mutation in the voltage-sensing domain is involved in switching the gating polarity of hERG. | 0 |
| 37769355 | 2024 | Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes. | 1 |
| 37923359 | 2024 | Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells. | 0 |
| 38086455 | 2024 | Functional and clinical characterization of a novel homozygous KCNH2 missense variant in the pore region of Kv11.1 leading to a viable but severe long-QT syndrome. | 0 |
| 38181028 | 2024 | Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome. | 0 |
| 38181928 | 2024 | Dissecting the associations of KCNH2 genetic polymorphisms with various types of cardiac arrhythmias. | 0 |
| 38219013 | 2024 | Clinical interpretation of KCNH2 variants using a robust PS3/BS3 functional patch-clamp assay. | 3 |
| 38317233 | 2024 | An LQT2-related mutation in the voltage-sensing domain is involved in switching the gating polarity of hERG. | 0 |
| 36269083 | 2023 | Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance. | 1 |
Citation
Dessen P
KCNH2 (potassium voltage-gated channel subfamily H member 2)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/45971/kcnh2
